T-Squeeze-PFE(target $__)|2/20
Today’s Change (Mar 16, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
Simple 50/50 split between Pfizer (PFE) and cash, likely for a short window. No scheduled rebalancing; adjust only if the Pfizer weight drifts a lot. Concentrated in one healthcare stock, with a cash cushion.
It holds two things: cash (uninvested dollars) and Pfizer stock (ticker PFE, a large U.S. drug company). It splits money about 50/50 between them. There’s no routine rebalancing; a 5% drift band suggests it would only be adjusted if Pfizer moves far from 50%. The name hints it was meant for Jan 23–Feb 20 and may have started in Accenture (ACN) before switching to Pfizer.
Out-of-sample tests show this simple 50/50 Pfizer-cash strategy delivering steadier, lower-volatility returns with downside protection versus the S&P 500, thanks to a cash buffer and minimal trading—ideal for short windows.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| 0.03 | 0.72 | 0.26 | 0.51 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 2,661.16% | 10.55% | -2.02% | -1.16% | 0.63 | |
| 3,092.78% | 10.05% | -2.78% | 5.98% | 0.49 |
Initial Investment
$10,000.00
Final Value
$319,277.85Regulatory Fees
$0.00
Total Slippage
$1.00
Invest in this strategy
OOS Start Date
Feb 18, 2026
Trading Setting
Threshold 5%
Type
Stocks
Category
Single-stock, healthcare/pharma, cash buffer, buy-and-hold, threshold rebalancing, short-term window
Tickers in this symphonyThis symphony trades 1 assets in total
Ticker
Type
PFE
Pfizer Inc.
Stocks